Je Hwan Lee (Je-Hwan Lee)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 28

Top Venues

Leukemia

Journal of Korean medical science

Bone marrow transplantation

British journal of haematology

Asan Medical Center, University of Ulsan College of Medicine

Chungbuk National University College of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Asan Medical Center, University of Ulsan College of Medicine May 01 1994

South Korea

Professor :: Hematology

Republic of Korea Army Mar 01 1991 - May 01 1994

South Korea

Army Physician :: Mandatory Military Service

Education History

Chungbuk National University College of Medicine Mar 01 1998 - Feb 28 2001

South Korea

PHD

University of Ulsan College of Medicine Mar 01 1995 - Feb 28 1997

South Korea

MSC

Publications

Bon-Kwan Koo, Eun-Ji Choi, Ju Hyun Moon, Ji Yun Kim, Hyunkyung Park, Han-Seung Park, Yunsuk Choi, Jung-Hee Lee, Kyoo-Hyung Lee, Eun Kyung Choi, Eunji Kim, Je Hwan Lee, Eun-Hye Hur
Synergistic effect of FMS-like tyrosine kinase-3 (FLT3) inhibitors combined with a CDK7 inhibitor in FLT3-ITD-mutated acute myeloid leukemia. Blood cancer journal 14 (1) (2024)
Eun-Ji Choi, Jin-Hee Han, Hyunkyung Park, Han-Seung Park, Yunsuk Choi, Jung-Hee Lee, Kyoo-Hyung Lee, Young-Shin Lee, Young-Ah Kang, Mijin Jeon, Hyeran Kang, Ji Min Woo, Je Hwan Lee
Lower incidence of acute graft-versus-host disease with post-transplantation cyclophosphamide compared to anti-thymocyte globulin in higher-risk myelodysplastic syndrome. Bone marrow transplantation (2024)
Alexander Röth, Guang-Sheng He, Hongyan Tong, Zenghua Lin, Xiaoqin Wang, Chatree Chai-Adisaksopha, Je Hwan Lee, Andres Brodsky, Chattree Hantaweepant, Teresita E Dumagay, Roberta Demichelis-Gómez, Ponlapat Rojnuckarin, Jing Sun, Martin Höglund, Jun Ho Jang, Anna Gaya, Fernando Silva, Naoshi Obara, Richard J Kelly, Leigh Beveridge, Simon Buatois, Sammy Chebon, Brittany Gentile, Pontus Lundberg, Sasha Sreckovic, Jun-Ichi Nishimura, Antonio Maria Risitano, Bing Han
Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibition. American journal of hematology 99 (9) (2024)
Alexander Röth, Guang-Sheng He, Hongyan Tong, Zenghua Lin, Xiaoqin Wang, Chatree Chai-Adisaksopha, Je Hwan Lee, Andres Brodsky, Chattree Hantaweepant, Teresita E Dumagay, Roberta Demichelis-Gómez, Ponlapat Rojnuckarin, Jing Sun, Martin Höglund, Jun Ho Jang, Anna Gaya, Fernando Silva, Naoshi Obara, Richard J Kelly, Leigh Beveridge, Simon Buatois, Sammy Chebon, Brittany Gentile, Pontus Lundberg, Sasha Sreckovic, Jun-Ichi Nishimura, Antonio Maria Risitano, Bing Han
Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibition. American journal of hematology (2024)
Eun-Ji Choi, Jin-Hee Han, Hyunkyung Park, Han-Seung Park, Yunsuk Choi, Jung-Hee Lee, Kyoo-Hyung Lee, Young-Shin Lee, Young-Ah Kang, Mijin Jeon, Hyeran Kang, Ji Min Woo, Je Hwan Lee
Lower incidence of acute graft-versus-host disease with post-transplantation cyclophosphamide compared to anti-thymocyte globulin in higher-risk myelodysplastic syndrome. Bone marrow transplantation 59 (9) (2024)
Jin Seok Kim, Jun Ho Jang, Deog-Yeon Jo, Seo-Yeon Ahn, Sung Soo Yoon, Je Hwan Lee, Sung-Hyun Kim, Chul Won Choi, Ho Jin Shin, Min-Kyoung Kim, Jae Hoon Lee, Yeung Chul Mun, Jee Hyun Kong, BokJin Hyun, HyunSun Nam, Eunhye Kim, Min Joo Kwak, Yong Kyun Won, Jong Wook Lee
Long-Term Efficacy and Safety of Eculizumab in Patients With Paroxysmal Nocturnal Hemoglobinuria and High Disease Burden: Real-World Data From Korea. Journal of Korean medical science 38 (41) (2023)
Kyoo Hyung Lee, Sewon Lee, Young Hoon Park, Yeung Chul Mun, Eun-Ji Choi, Yunsuk Choi, Han-Seung Park, Jung-Hee Lee, Je Hwan Lee, Soo-Yeon Park, Suk Ran Yoon, Inpyo Choi
Interleukin-15 and -21-activated, donor-derived NK cell infusion after haploidentical HCT in high-risk AML and MDS-a cohort analysis. Leukemia 38 (2) (2023)
Kyoo Hyung Lee, Sewon Lee, Young Hoon Park, Yeung Chul Mun, Eun-Ji Choi, Yunsuk Choi, Han-Seung Park, Jung-Hee Lee, Je Hwan Lee, Soo-Yeon Park, Suk Ran Yoon, Inpyo Choi
Interleukin-15 and -21-activated, donor-derived NK cell infusion after haploidentical HCT in high-risk AML and MDS-a cohort analysis. Leukemia 38 (2) (2023)
Kyoo Hyung Lee, Sewon Lee, Young Hoon Park, Yeung Chul Mun, Eun-Ji Choi, Yunsuk Choi, Han-Seung Park, Jung-Hee Lee, Je Hwan Lee, Soo-Yeon Park, Suk Ran Yoon, Inpyo Choi
Interleukin-15 and -21-activated, donor-derived NK cell infusion after haploidentical HCT in high-risk AML and MDS-a cohort analysis. Leukemia (2023)
Kyoo Hyung Lee, Suk Ran Yoon, Jeong-Ryeol Gong, Eun-Ji Choi, Hun Sik Kim, Chan-Jeoung Park, Sung-Cheol Yun, Soo-Yeon Park, Sol-Ji Jung, Hanna Kim, Soo Yun Lee, Haiyoung Jung, Jae-Eun Byun, Mirang Kim, Seon-Young Kim, Jeong-Hwan Kim, Je Hwan Lee, Jung-Hee Lee, Yunsuk Choi, Han-Seung Park, Young-Shin Lee, Young-Ah Kang, Mijin Jeon, Jimin Woo, Hyeran Kang, Seunghyun Baek, Su Mi Kim, Hoon-Min Kim, Kwang-Hyun Cho, Inpyo Choi
The infusion of ex vivo, interleukin-15 and -21-activated donor NK cells after haploidentical HCT in high-risk AML and MDS patients-a randomized trial. Leukemia (2023)
Kyoo Hyung Lee, Sewon Lee, Young Hoon Park, Yeung Chul Mun, Eun-Ji Choi, Yunsuk Choi, Han-Seung Park, Jung-Hee Lee, Je Hwan Lee, Soo-Yeon Park, Suk Ran Yoon, Inpyo Choi
Interleukin-15 and -21-activated, donor-derived NK cell infusion after haploidentical HCT in high-risk AML and MDS-a cohort analysis. Leukemia 38 (2) (2023)
Kyoo Hyung Lee, Sewon Lee, Young Hoon Park, Yeung Chul Mun, Eun-Ji Choi, Yunsuk Choi, Han-Seung Park, Jung-Hee Lee, Je Hwan Lee, Soo-Yeon Park, Suk Ran Yoon, Inpyo Choi
Interleukin-15 and -21-activated, donor-derived NK cell infusion after haploidentical HCT in high-risk AML and MDS-a cohort analysis. Leukemia 38 (2) (2023)
Kyoo Hyung Lee, Sewon Lee, Young Hoon Park, Yeung Chul Mun, Eun-Ji Choi, Yunsuk Choi, Han-Seung Park, Jung-Hee Lee, Je Hwan Lee, Soo-Yeon Park, Suk Ran Yoon, Inpyo Choi
Interleukin-15 and -21-activated, donor-derived NK cell infusion after haploidentical HCT in high-risk AML and MDS-a cohort analysis. Leukemia 38 (2) (2023)
Soo-Mee Bang, Byung Soo Kim, Ik-Chan Song, Cynthia Llamas, Yinghui Duan, Ji-Young Jeong, Je Hwan Lee
Real-World Treatment Patterns and Clinical Outcomes in Korean Patients With AML Ineligible for First-Line Intensive Chemotherapy: A Subanalysis of the CURRENT Study, a Non-Interventional, Retrospective Chart Review. Journal of Korean medical science 38 (44) (2023)
Eun-Ji Choi, Young-Uk Cho, Eun-Hye Hur, Han-Seung Park, Yunsuk Choi, Jung-Hee Lee, Kyoo-Hyung Lee, Miyoung Kim, Sang-Hyun Hwang, Seongsoo Jang, Chan-Jeoung Park, Eul-Ju Seo, Je Hwan Lee
Clinical implications and genetic features of clonal cytopenia of undetermined significance compared to lower-risk myelodysplastic syndrome. British journal of haematology 198 (4) (2022)
Alexander E Perl, Naoko Hosono, Pau Montesinos, Nikolai A Podoltsev, Giovanni Martinelli, Nicki Panoskaltsis, Christian Recher, Catherine C Smith, Mark J Levis, Stephen A Strickland, Christoph Röllig, Marco Groß-Langenhoff, Wen-Chien Chou, Je Hwan Lee, Hisayuki Yokoyama, Nahla Hasabou, Qiaoyang Lu, Ramon V Tiu, Jessica K Altman
Clinical outcomes in patients with relapsed/refractory FLT3-mutated acute myeloid leukemia treated with gilteritinib who received prior midostaurin or sorafenib. Blood cancer journal 12 (5) (2022)
Eun-Ji Choi, Tae Joon Jun, Han-Seung Park, Jung Hee Lee, Kyoo Hyung Lee, Young Hak Kim, Young-Shin Lee, Young-Ah Kang, Mijin Jeon, Hyeran Kang, Ji Min Woo, Je Hwan Lee
Predicting Long-term Survival After Allogeneic Hematopoietic Cell Transplantation in Patients With Hematologic Malignancies: Machine Learning-Based Model Development and Validation. JMIR medical informatics 10 (3) (2022)
Eunice S Wang, Pau Montesinos, Mark D Minden, Je Hwan Lee, Michael Heuser, Tomoki Naoe, Wen-Chien Chou, Kamel Laribi, Jordi Esteve, Jessica K Altman, Violaine Havelange, Anne-Marie Watson, Carlo B Gambacorti-Passerini, Elżbieta Patkowska, Shufang Liu, Ruishan Wu, Nisha Philipose, Jason E Hill, Stanley C Gill, Elizabeth Shima Rich, Ramon V Tiu
Phase 3 trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed FLT3mut+ AML ineligible for intensive chemotherapy. Blood 140 (17) (2022)
Gyungah Kim, Eun-Ji Choi, Han-Seung Park, Jung Hee Lee, Je Hwan Lee, Kyoo Hyung Lee
A Case Report of Immune Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. Journal of Korean medical science 36 (43) (2021)
Ari Ahn, Chan Jeoung Park, Min Sun Kim, Young-Uk Cho, Seongsoo Jang, Mi-Hyun Bae, Jung Hee Lee, Je Hwan Lee, Kyung-Nam Koh, Ho Joon Im
Granulocytic and Monocytic Myeloid-Derived Suppressor Cells are Functionally and Prognostically Different in Patients with Chronic Myeloid Leukemia. Annals of laboratory medicine 41 (5) (2021)
Jun Hong Park, Je Hwan Lee, Jung Hee Lee, Han-Seung Park, Eun-Ji Choi, Young-Ah Kang, Hyeran Kang, Ji Min Woo, Young-Shin Lee, Mijin Jeon, Kyoo Hyung Lee
Incidence, Management, and Prognosis of Graft Failure and Autologous Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation. Journal of Korean medical science 36 (23) (2021)
Eun-Ji Choi, Je Hwan Lee, Hawk Kim, Yunsuk Choi, Won-Sik Lee, Sang-Min Lee, Jun-Hong Park, Han-Seung Park, Jung-Hee Lee, Kyoo-Hyung Lee, null null
Autologous hematopoietic cell transplantation following high-dose cytarabine consolidation for core-binding factor-acute myeloid leukemia in first complete remission: a phase 2 prospective trial. International journal of hematology 113 (6) (2021)
Jae-Cheol Jo, Jin Seok Kim, Je Hwan Lee, Jung-Hee Lee, Sung-Nam Lim, Sang Min Lee, Sung-Soo Yoon, In-Ho Kim, Sung Hwa Bae, Yoo Jin Lee, Yunsuk Choi, Won-Sik Lee
Busulfan, etoposide, cytarabine, and melphalan (BuEAM) as a conditioning regimen for autologous stem cell transplantation in patients with non-Hodgkin lymphoma (NHL). Bone marrow transplantation 55 (7) (2020)
Jae-Ho Yoon, Keon Hee Yoo, Ki Woong Sung, Chul Won Jung, Jin Seok Kim, Seung Min Hahn, Hyoung Jin Kang, Je Hwan Lee, Ho Joon Im, Jae-Sook Ahn, Hoon Kook, Bin Cho, Jong Wook Lee
Validation of treatment outcomes according to revised severity criteria from European Society for Blood and Marrow Transplantation (EBMT) for sinusoidal obstruction syndrome/veno-occlusive disease (SOS/VOD). Bone marrow transplantation 54 (8) (2019)
Eun-Ji Choi, Je Hwan Lee, Han-Seung Park, Jung-Hee Lee, Miee Seol, Young-Shin Lee, Young-Ah Kang, Mijin Jeon, Ji Min Woo, Hyeran Kang, Kyoo-Hyung Lee
Androgen therapy for patients with lower-risk myelodysplastic syndrome and significant cytopenia: a retrospective study. British journal of haematology 187 (1) (2019)
Hye-Young Lee, Chan Jeoung Park, Ari Ahn, Min-Young Lee, Young-Uk Cho, Seongsoo Jang, Eul-Ju Seo, Kyoo Hyung Lee, Je Hwan Lee
Two Rare Cases of Therapy-Related Acute Lymphoblastic Leukemia in Patients With Plasma Cell Myeloma. Annals of laboratory medicine 39 (5) (2019)
Hawk Kim, Je Hwan Lee, Won-Sik Lee, Inho Kim, Joon Ho Moon, Chul Won Choi, Ho Sup Lee, Jinny Park, Yunsuk Choi, Ho-Jin Shin, Su-Hee Cho, Kyoung Ha Kim, Sung-Yong Kim, Yoo-Jin Kim, null null
Lenalidomide as a second-line therapy after failure of hypomethylating agents in patients with myelodysplastic syndrome. British journal of haematology 186 (5) (2019)
Jun Ho Jang, Jin Seok Kim, Sung Soo Yoon, Je Hwan Lee, Yeo Kyeoung Kim, Deog-Yeon Jo, Joo-Seop Chung, Sang Kyun Sohn, Jong Wook Lee
Predictive Factors of Mortality in Population of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Results from a Korean PNH Registry. Journal of Korean medical science 31 (2) (2016)

Je Hwan Lee.css-eqlu8i{font-size:small;padding-left:4px;} (Je-Hwan Lee)

Publication Activity (10 Years)

Top Topics

Top Venues

Je Hwan Lee (Je-Hwan Lee)